Andrew Left: Valeant May See Higher Before It Sees Lower

The transcript discusses a trading strategy involving Valley and Mallinckrodt stocks, highlighting the potential for a turnaround in Valley's business under new leadership. It also addresses perceived unfairness in market practices, particularly in the pharmaceutical sector, and critiques a Senate hearing involving key industry figures.

What optimistic scenario did the speaker mention regarding the future of the company?

What was the speaker's opinion on the actions taken by Claire McCaskill regarding Mallinckrodt?